argenx (ARGX) · efgartigimod
Narrower window · A neutral label from comparing the two stated windows. It says nothing about the program’s results.
Before
Stated timing: 2027
UNITY study ongoing in primary Sjögren’s disease; topline results expected in 2027
EX-99.1 · filed · SEC filing
After
Stated timing: second half of 2027
UNITY remains ongoing, with topline Phase 3 results expected in the second half of 2027
SEC original · filed · SEC filing
Data as of . Both sentences are quoted from the SEC filings linked above and matched to them.
Source: ORION, orionbiotechai.com/changes/ARGX-efgartigimod-2026-03-19, data as of Oct 13, 2026
https://www.orionbiotechai.com/changes/ARGX-efgartigimod-2026-03-19
argenx (ARGX) pipeline and stated timing · Calendar · Companies A–Z